Biotechs/Therapeutics still breaking out

Lately the biotech/gene and therapeutics issues have been all trading up on above average volume as money rotates into the group for the first time in a while.  This area looks to be establishing itself as an emerging leadership area.  Today two new issues, ILMN and NABI pop up on the FusionIQ Short Squeeze screen.  Both have sizeable float adjusted short interests (24 % and 11 % respectively) and higher point and figure price targets ($ 111 and $ 8.75 respectively). 

 

Given the rotation to biotech these two names look to offer solid near-term return potential.

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Comments
Leave a comment
Name
Email Address
URL
Remember personal info?
Comments
Blog Home
RSS Feed
Categories
Barron's
Breakouts/Breakdowns
ChartWatch
Company in the News
Earnings
Equity Timing Signals (Buy/Sell)
Index Study
Market Data
Media
New Highs
Sector Group Rankings
Short Squeeze Screen
Stock Analysis
Total Stocks Rankings
Archives
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007